Ling, Yihong
155  Ergebnisse:
Personensuche X
?
2

Postoperative Adjuvant Hepatic Arterial Infusion Chemothera..:

Li, Shao-Hua ; Mei, Jie ; Cheng, Yuan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082249/.  , 2023
 
?
 
?
 
?
 
?
6

Deep Learning Model for Predicting the Pathological Complet..:

Lou, Xiaoying ; Zhou, Niyun ; Feng, Lili...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214314/.  , 2022
 
?
7

The prognostic value and molecular properties of tertiary l..:

Ling, Yihong ; Zhong, Jian ; Weng, Zelin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574489/.  , 2022
 
?
8

Impacts of neoadjuvant chemoradiotherapy on the immune land..:

Wen, Jing ; Fang, Shuogui ; Hu, Yi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699982/.  , 2022
 
?
9

Clinical actionability of triaging DNA mismatch repair defi..:

Jiang, Wu ; Mei, Wei-Jian ; Xu, Shuo-Yu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240789/.  , 2022
 
?
 
?
11

Clinicopathological and Prognostic Characteristics of Esoph..:

Li, Peng ; Li, Yang ; Zhang, Chao...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991578/.  , 2021
 
?
 
?
13

C-C motif chemokine 14 as a novel potential biomarker for p..:

Cai, Yubo ; Ling, Yihong ; Huang, Lingbo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068588/.  , 2020
 
?
14

Treatment optimization for recurrent hepatocellular carcino..:

Lu, Liang‐He ; Mei, Jie ; Kan, Anna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196061/.  , 2020
 
?
15

Resection vs. Sorafenib for Hepatocellular Carcinoma With M..:

Mei, Jie ; Li, Shao-Hua ; Wang, Qiao-Xuan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214621/.  , 2020
 
1-15